Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting 'Direct to LAT' in selected groups.
Aged
Aged, 80 and over
Asbestos
/ adverse effects
Biomarkers, Tumor
Environmental Exposure
/ adverse effects
Female
Humans
Lung Neoplasms
/ diagnosis
Male
Pleura
/ pathology
Pleural Effusion, Malignant
/ diagnosis
Pleural Neoplasms
/ diagnosis
Predictive Value of Tests
Prognosis
Retrospective Studies
Cytology
Lung cancer
Malignant pleural effusion
Mesothelioma
Pleural effusion
Journal
Lung cancer (Amsterdam, Netherlands)
ISSN: 1872-8332
Titre abrégé: Lung Cancer
Pays: Ireland
ID NLM: 8800805
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
15
01
2019
revised:
09
04
2019
accepted:
15
05
2019
entrez:
16
6
2019
pubmed:
16
6
2019
medline:
7
3
2020
Statut:
ppublish
Résumé
Negative effusion cytology is more common in certain forms of Malignant Pleural Effusion (MPE) and results in pathway delay. Local Anaesthetic Thoracoscopy (LAT) is extremely sensitive and safe but cannot be offered to all. A stratified pathway, including 'Direct to LAT' in selected cases could enhance patient experience but requires reliable baseline predictors of unhelpful cytology, including both negative (no malignant cells) and incomplete results (malignant cells identified but predictive markers failed), since pleural biopsies will be required in the latter for optimal management. This retrospective analysis of a prospective multi-centre study, sought to identify baseline features for pathway rationalization. 363/638 (57%) of patients recruited to the DIAPHRAGM study (ISRCTN10079972) were included. Prospective data, including final diagnoses, asbestos exposure and fluid cytology results were supplemented by retrospective Computed Tomography (CT) and predictive marker reports. Independent predictors of negative and incomplete cytology were determined by multivariable logistic regression. Contingency tables were used to assess diagnostic value of cytology in associated phenotypes. 238/363 (66%) patients were diagnosed with MPE (18 tumour types). Fluid cytology was negative in 151/238 (63%) and independently associated with asbestos-exposure (Odds Ratio (OR) 5.34) and a malignant CT (OR 2.25). When both features were recorded the sensitivity and negative predictive value of fluid cytology were 19% (95% CI 11-30%) and 9% (95% CI 4-20%)), respectively. Cytology was incomplete in 34/238 (14%), i.e. 47% of positive cytology cases) but was not associated with any baseline feature. ORs for incomplete cytology in Ovarian, Breast, Renal and Lung Cancer were 83, 22, 21 and 9, respectively. Negative cytology is extremely likely in patients with asbestos exposure and a malignant CT report. A 'Direct-to-LAT' approach may be appropriate in this setting. No baseline predictors of incomplete cytology were identified.
Identifiants
pubmed: 31200818
pii: S0169-5002(19)30462-3
doi: 10.1016/j.lungcan.2019.05.017
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Asbestos
1332-21-4
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
123-129Subventions
Organisme : Chief Scientist Office
ID : ETM/285
Pays : United Kingdom
Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.